STAT

Grassroots group tries to get a new kind of doctor in the House (and Senate)

Today, 13 of the 15 doctors in Congress are Republicans, and all are men. A private group of more than 8,000 Democratic female doctors is trying to change that.

WASHINGTON — Since 1960, nearly 50 doctors have traded in their white coats for the suit jackets required in the halls of Congress. And there’s been one remarkable constant: The doctors-turned-legislators in those blazers have been overwhelmingly male and overwhelmingly Republican. Just a handful were Democrats and only two were women. None were both.

This year, Dr. Ramsey Ellis, a progressive hand surgeon from the Chicago suburbs, is working to change that. She’s throwing the support of a private group of more than 8,000 Democratic female doctors across the nation behind a slate of eight congressional candidates with the same qualifications: all women, all Democrats, and all doctors — pediatricians, gynecologists, and ER physicians among them.

“Women are missing from public debate and physicians are missing,” Ellis, a former grassroots organizer for Hillary Clinton and the candidates lead for the group — called Physician Women for Democratic Principles — told STAT. “Given that a sixth of the American economy is health care, I think it’s time that [women] physicians step into the arena and tell the

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks